Impact of dioxins on antipyrine metabolism in firefighters

Toxicol Lett. 2016 May 27:250-251:35-41. doi: 10.1016/j.toxlet.2016.04.006. Epub 2016 Apr 8.

Abstract

Antipyrine (AP) metabolism was used to assess factors associated with the activity of hepatic oxidative enzymes in firefighters. Emphasis was placed on 3-hydroxymethylantipyrine (3HMAP), the metabolite with the greatest dependence on dioxin-inducible cytochrome P4501A2 (CYP1A2) activity. AP urinary metabolites were measured by HPLC in 38 male subjects from Eastern Siberia. Subjects were divided into three groups having similar ages and BMIs: current firefighters (n=11); former firefighters (n=17) and non-firefighters (n=10). Multiple regression models were constructed using the three major AP metabolites as a dependent variable to assess the influence of age, smoking as urinary cotinine concentration, dioxin exposure (as either WHO-TEQ or body burden), group, and CYP1A2*F (-163C>A) genotypes. Models for the proportion of dose excreted as the metabolite 3HMAP produced the best fit (adjusted R(2)=0.46, p<0.05). When the models were restricted to current firefighters, only those based on 3HMAP were statistically significant (adjusted R(2) of 0.80 (p<0.002)) due to contributions from urinary cotinine (β=0.56, p<0.01) and dioxin expressed as body burden (β=0.55, p=0.014). These results indicate that the antipyrine test can be used as metabolic probe of biological response to recent dioxin exposure provided the impact of smoking is carefully controlled.

Keywords: Antipyrine metabolism; Cytochrome P4501A2 (CYP1A2); Dioxin exposure; Firefighters; Urinary cotinine level.

MeSH terms

  • Adult
  • Antipyrine / analogs & derivatives
  • Antipyrine / metabolism*
  • Antipyrine / urine
  • Body Burden
  • Case-Control Studies
  • Chromatography, High Pressure Liquid
  • Cytochrome P-450 CYP1A2 / biosynthesis*
  • Cytochrome P-450 CYP1A2 / genetics
  • Cytochrome P-450 CYP1A2 Inducers / adverse effects*
  • Dioxins / adverse effects*
  • Enzyme Induction
  • Firefighters*
  • Genotype
  • Humans
  • Linear Models
  • Liver / drug effects*
  • Liver / enzymology
  • Male
  • Middle Aged
  • Models, Biological
  • Occupational Exposure / adverse effects*
  • Phenotype
  • Risk Assessment
  • Siberia
  • Smoking / adverse effects
  • Smoking / metabolism
  • Substrate Specificity
  • Urinalysis / methods

Substances

  • Cytochrome P-450 CYP1A2 Inducers
  • Dioxins
  • 3-hydroxymethylantipyrine
  • CYP1A2 protein, human
  • Cytochrome P-450 CYP1A2
  • Antipyrine